Healthcare stocks are lower with the NYSE Healthcare Sector
Index sliding 0.5% and shares of healthcare companies in the
S&P 500 down 0.2% as a group.
In company news, Biolase is up slightly more than 2.1% at $1.95
a share and the company today announcing a partnership with Auris
Surgical Robots to co-develop cataract-removal ophthalmologic
The new products will use BIOL's patented WaterLase YSGG
all-tissue atraumatic cutting device mounted on a unique robotic
operating system manufactured by Auris.
In other sector news,
(+) NVGN, Seeking Alpha report describes the drug-maker as "the
most exciting idea in biotech," predicting its share price will
soon soar on a "major partnership announcement."
(-) ATRS, Giving back gains during yesterday's session that
followed the FDA approving its Otrexup injection for adults with
Rheumatoid Arthritis, children with Polyarticular Idiopathic
Arthritis and adults with Psoriasis.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.